Implant stability in patients treated with platelet-rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors

Clin Exp Dent Res. 2020 Apr;6(2):236-243. doi: 10.1002/cre2.263. Epub 2019 Dec 6.

Abstract

Aims: The aim of the present study was to assess the association between dental implant stability and peripheral blood cell composition and levels of coagulation factors in patients treated with alveolar ridge preservation with platelet-rich fibrin (PRF) and bovine bone substitute.

Materials and methods: Fifty patients were included between 2015 and 2017. PRF was prepared from autologous blood, in which blood cells and coagulation factor levels were measured. PRF and bovine bone were placed in the socket, followed by closure with PRF membrane. Implants were placed 14 (±2.5) weeks postextraction. The implant stability quotient was measured at t = 0, t = 10 days, t = 7 weeks, and t = 17 weeks by resonance frequency analysis.

Results: Erythrocyte count was inversely associated with PRF membrane length, but not with implant stability. Conversely, platelet count did not correlate with membrane size but inversely correlated with implant stability at 7 and 17 weeks. In addition, implant stability was directly correlated with levels FXIII (t = 0, p < .01), active von Willebrand factor (VWF; t = 0 and 7 weeks, p < .05), and total VWF (t = 7 weeks, p = .012).

Conclusion: Implant stability following alveolar ridge preservation with PRF and bovine bone substitute is associated with circulating blood cells and coagulation factors. In particular, fibrin structure, VWF, and FXIII may be important modulators of implant stability.

Keywords: alveolar ridge preservation; blood cells; blood coagulation; implant stability; platelet-rich fibrin.

Publication types

  • Observational Study

MeSH terms

  • Aged
  • Alveolar Ridge Augmentation / methods*
  • Animals
  • Biomarkers / blood
  • Blood Coagulation Factors / analysis
  • Blood Transfusion, Autologous / methods
  • Bone Substitutes / administration & dosage*
  • Cattle
  • Dental Implantation, Endosseous / adverse effects*
  • Dental Restoration Failure*
  • Erythrocyte Count
  • Female
  • Heterografts / transplantation
  • Humans
  • Male
  • Middle Aged
  • Platelet-Rich Fibrin*
  • Prospective Studies
  • Tooth Extraction / adverse effects
  • Tooth Loss / surgery
  • Tooth Socket / transplantation
  • Treatment Outcome

Substances

  • Biomarkers
  • Blood Coagulation Factors
  • Bone Substitutes